0.32% -0.010

Dna X Inc (SONM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Dna X Inc Stock (SONM) Company Profile

Technology (789)

650-378-8100

4445 EASTGATE MALL, SAN DIEGO, TX

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SONM's Discussions on Twitter

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SONM Dna X Inc	3.07	4.66M	27.40M	-17.12M	-24.99M	-106.89
MSFT Microsoft Corp	384.18	2.83T	318.27B	125.22B	72.92B	16.79
ORCL Oracle Corp	118.42	345.77B	67.36B	17.31B	-23.69B	5.8248
PLTR Palantir Technologies Inc	123.46	295.76B	5.22B	2.29B	2.69B	0.8876
CRWD Crowdstrike Holdings Inc	183.51	186.77B	5.09B	-24.89M	1.43B	-0.0471
FTNT Fortinet Inc	153.49	111.03B	7.11B	1.95B	2.44B	2.5883

Dna X Inc Stock (SONM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-10-31	Herabstufung	Oppenheimer	Outperform → Perform
2019-07-18	Eingeleitet	B. Riley FBR	Buy
2019-07-09	Hochstufung	National Securities	Neutral → Buy
2019-06-10	Eingeleitet	National Securities	Neutral
2019-06-04	Eingeleitet	Lake Street	Buy
2019-06-04	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Dna X Inc Aktie (SONM) Neueste Nachrichten

Finanzdaten der Dna X Inc-Aktie (SONM)

Dna X Inc (SONM)

Dna X Inc Stock (SONM) Company Profile

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Dna X Inc Stock (SONM) Upgrades & Downgrades

Dna X Inc Aktie (SONM) Neueste Nachrichten

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times

12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga

How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica

SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et

Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail

12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga

DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart

DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et

Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS

Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS

DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com

Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review

Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com

Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView

Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView

Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView

12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga

WhatsApp CEO Kunal Shah said Indians don’t value time. Sanskrit scholar responds - ThePrint

Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView

Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk

SONM Q3 2024 Earnings: Loss Narrows Significantly, Beats ExpectationsEarnings Miss Streak - newsline.com

Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant - Stock Titan

[EFFECT] DNA X, Inc. SEC Filing - Stock Titan

DNA X | EFFECT: Others - Moomoo

DNA X Inc. (SONM) Faces Downside Pressure as Support Levels ApproachRVOL Spike - newsline.com

DNA X (SONM) deregisters 350M common shares tied to Chardan resale - Stock Titan

DNA Research Shows Your Muscles Remember How Strong and Fit You Once Were - inc.com

11 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga

12 Information Technology Stocks Moving In Friday's Pre-Market Session - Benzinga

DNA X, Inc. (formerly Sonim Technologies) Terminates Material Definitive Agreement – SEC Form 8-K Filing June 2026 - Minichart

Sonim Technologies Ends Major Equity Purchase Agreement - TipRanks

DNA X Ends $500 Million ChEF Equity Facility and Related Registration Rights With Chardan - TradingView

DNA X (NASDAQ: SONM) terminates $500M Chardan equity facility - Stock Titan

Natera Inc stock (US6323071042): insider sales and new oncology board appointments in focus - AD HOC NEWS

DNA X: Q1 Earnings Snapshot - AOL.com

Lotus Technology Inc. Unveils Eletre X: A Revolutionary Hybrid SUV Offering 1,200+ km Range and Supercar Performance Starting at €96,990 - Quiver Quantitative

12 Information Technology Stocks Moving In Tuesday's Intraday Session - Benzinga

Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire

SONMDNA X Inc Short Interest - Finviz

SONM Q3 2024 Earnings: EPS Surprises to the Upside with 22.76% Beat; Stock Rises 4%Preliminary Results - The Legal Advocate

SONM Q3 2024 Earnings: EPS Surprises Higher by 22.76%, Stock Rises Over 4%One-Time Gain Impact - The Legal Advocate

SONM Q3 2024 Earnings: EPS Beats Estimates by 22.76% Amid Cost DisciplineRetail Earnings Report - thelegaladvocate.com

DNA X Inc. (SONM) Shares Rise Nearly 6% as Buyer Interest Surges Near Key SupportBullish Sentiment - dars.gov.et

S&P 500 Edges Higher as Healthcare and Tech Rally Outweigh Utility DeclinePPI Inflation Report - thelegaladvocate.com

DNA X Inc. (SONM) Rallies 4.18% as Momentum Builds Toward Key ResistanceEntry Point Alerts - The Legal Advocate

DNA X, Inc. Enters Securities Purchase Agreement with DNA Holdings Venture, Inc. and Issues Convertible Note – Key Details and Terms - Minichart

DNA X Stock Looks at Nasdaq Deadline After Latest Financing - Bez Kabli

Sonim Technologies Faces Nasdaq Delisting After New Financing - TipRanks

DNA X Received Notice of Delisting - TradingView

Finanzdaten der Dna X Inc-Aktie (SONM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SONM